中国药理学通报2025,Vol.41Issue(1) :7-12.DOI:10.12360/CPB202402004

去亚甲基小檗碱的药理作用研究进展

Advances in pharmacological effects of demethyleneberberine

李靖琪 张琪 陈雨桐 仝永斌 鲁澄宇
中国药理学通报2025,Vol.41Issue(1) :7-12.DOI:10.12360/CPB202402004

去亚甲基小檗碱的药理作用研究进展

Advances in pharmacological effects of demethyleneberberine

李靖琪 1张琪 1陈雨桐 1仝永斌 1鲁澄宇1
扫码查看

作者信息

  • 1. 广东医科大学药学院,广东东莞 523808
  • 折叠

摘要

去亚甲基小檗碱(demethyleneberberine,DMB)是小檗碱在体内的主要代谢产物之一,其具有广泛的药理特性.大量研究表明其具有改善感染、抗炎、抗纤维化、抑制癌细胞、调节血脂等多种生物活性,而且在神经退行性疾病治疗领域有巨大潜力.该文通过对DMB药理作用及其机制进行系统概述,以期为深入理解其药理作用及合理开发提供科学依据.

Abstract

Demethyleneberberine(DMB),one of the active me-tabolite of berberine,displays versatile pharmacological proper-ties.Numerous studies indicate diverse biological activities,such as actions against infection,inflammation,fibrosis,cancer cells,blood lipids,etc.It presents considerable potential in treating neurodegenerative diseases.This article provides a con-cise review of the pharmacological actions and mechanisms made in demethyleneberberine research to facilitate a deeper under-standing of its pharmacology and provide a scientific foundation for its prudent development.

关键词

去亚甲基小檗碱/药理作用/抗感染/抗炎/肝保护/神经保护

Key words

demethyleneberberine/pharmacological effects/anti-infection/anti-inflammation/hepatoprotection/neuropro-tection

引用本文复制引用

出版年

2025
中国药理学通报
中国药理学会

中国药理学通报

北大核心
影响因子:1.54
ISSN:1001-1978
段落导航相关论文